Clay B. Siegall

2018

In 2018, Clay B. Siegall earned a total compensation of $18.1M as President and CEO at Seattle Genetics, a 110% increase compared to previous year.

Compensation breakdown

Bonus$2,000
Non-Equity Incentive Plan$1,409,995
Option Awards$7,539,792
Salary$918,554
Stock Awards$8,217,394
Other$19,302
Total$18,107,037

Siegall received $8.2M in stock awards, accounting for 45% of the total pay in 2018.

Siegall also received $2K in bonus, $1.4M in non-equity incentive plan, $7.5M in option awards, $918.6K in salary and $19.3K in other compensation.

Rankings

In 2018, Clay B. Siegall's compensation ranked 209th out of 14,244 executives tracked by ExecPay. In other words, Siegall earned more than 98.5% of executives.

ClassificationRankingPercentile
All
209
out of 14,244
99th
Division
Manufacturing
66
out of 5,758
99th
Major group
Chemicals And Allied Products
24
out of 2,119
99th
Industry group
Drugs
20
out of 1,808
99th
Industry
Biological Products, Except Diagnostic Substances
6
out of 339
98th

Pay ratio

Clay B. Siegall's Pay$18,107,037
Median Employee's Pay$198,658
Pay Ratio

91

to 1

In 2018, the annual total compensation of Clay B. Siegall was $18,107,037.

The annual total compensation of the median employee at Seattle Genetics was $198,658.

The ratio of Clay B. Siegall's pay to the pay of median employee was therefore 91 to one.

Source: SEC filing on April 4, 2019.

Siegall's colleagues

We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2018.

2018

Roger Dansey

Seattle Genetics

Chief Medical Officer

2018

Todd Simpson

Seattle Genetics

Chief Financial Officer

2018

Vaughn Himes

Seattle Genetics

Chief Technical Officer

2018

Darren Cline

Seattle Genetics

Former Executive Vice President, Commercial

2018

Jean Liu

Seattle Genetics

General Counsel

News

You may also like